Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2023 | 4 |
2024 | 2 |
Search Results
6 results
Results by year
Filters applied: . Clear all
Page 1
Immune Checkpoint Receptor/Ligand Expression and Chemotherapy in Colorectal Cancer.
Cancers (Basel). 2023 Feb 1;15(3):914. doi: 10.3390/cancers15030914.
Cancers (Basel). 2023.
PMID: 36765872
Free PMC article.
microRNAs in Liquid Biopsy: The Way to a Simple and Rapid Test for Early Colorectal Cancer Diagnosis?
Matis S, Poggi A, Benelli R.
Matis S, et al.
Cancers (Basel). 2023 Jan 28;15(3):797. doi: 10.3390/cancers15030797.
Cancers (Basel). 2023.
PMID: 36765755
Free PMC article.
Item in Clipboard
Evolution of 3D Cultures: Toward Tailored Preclinical Models.
Benelli R, Zocchi MR, Poggi A.
Benelli R, et al.
Cancers (Basel). 2023 Jan 14;15(2):515. doi: 10.3390/cancers15020515.
Cancers (Basel). 2023.
PMID: 36672464
Free PMC article.
Item in Clipboard
EGFR-Targeted Antibody-Drug Conjugate to Different Aminobisphosphonates: Direct and Indirect Antitumor Effects on Colorectal Carcinoma Cells.
Pisheh L, Matis S, Taglieri M, Di Gregorio L, Benelli R, Poggi A.
Pisheh L, et al.
Cancers (Basel). 2024 Mar 22;16(7):1256. doi: 10.3390/cancers16071256.
Cancers (Basel). 2024.
PMID: 38610932
Free PMC article.
Item in Clipboard
Antibody-Drug Conjugate Made of Zoledronic Acid and the Anti-CD30 Brentuximab-Vedotin Exert Anti-Lymphoma and Immunostimulating Effects.
Morelli F, Matis S, Benelli R, Salvini L, Zocchi MR, Poggi A.
Morelli F, et al.
Cells. 2024 May 17;13(10):862. doi: 10.3390/cells13100862.
Cells. 2024.
PMID: 38786084
Free PMC article.
Item in Clipboard
Priming of Colorectal Tumor-Associated Fibroblasts with Zoledronic Acid Conjugated to the Anti-Epidermal Growth Factor Receptor Antibody Cetuximab Elicits Anti-Tumor Vδ2 T Lymphocytes.
Fernandez JLC, Benelli R, Costa D, Campioli A, Tavella S, Zocchi MR, Poggi A.
Fernandez JLC, et al.
Cancers (Basel). 2023 Jan 18;15(3):610. doi: 10.3390/cancers15030610.
Cancers (Basel). 2023.
PMID: 36765569
Free PMC article.
Item in Clipboard
Cite
Cite